OR4A18P

Across TCGA pan-cancer cohorts, OR4A18P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR4A18P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher OR4A18P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated OR4A18P expression acts as an unfavorable survival marker, although some lineages such as BRCA and STAD show a favorable association.

BRCA, UCEC, and LAML are the cancer types where OR4A18P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.968	0.768	.005	84	view →
UCEC	OS	Tertile	All	0.351	0.684	.007	54	view →
LAML	DFS	Tertile	All	0.184	0.585	<.001	36	view →
KIRC	DFS	Tertile	IV	0.090	0.641	<.001	18	view →
THCA	DFS	Tertile	All	0.573	0.896	.015	18	view →
GBM	OS	Tertile	All	0.086	0.415	.010	9	view →
STAD	DFS	Tertile	III,IV	0.746	0.287	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR4A18P–BRCA (DFS)

Open the BRCA breakdown →